These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

915 related items for PubMed ID: 25911511

  • 1. Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.
    Cenac N, Bautzova T, Le Faouder P, Veldhuis NA, Poole DP, Rolland C, Bertrand J, Liedtke W, Dubourdeau M, Bertrand-Michel J, Zecchi L, Stanghellini V, Bunnett NW, Barbara G, Vergnolle N.
    Gastroenterology; 2015 Aug; 149(2):433-44.e7. PubMed ID: 25911511
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin E2, Produced by Mast Cells in Colon Tissues From Patients With Irritable Bowel Syndrome, Contributes to Visceral Hypersensitivity in Mice.
    Grabauskas G, Wu X, Gao J, Li JY, Turgeon DK, Owyang C.
    Gastroenterology; 2020 Jun; 158(8):2195-2207.e6. PubMed ID: 32084424
    [Abstract] [Full Text] [Related]

  • 3. Histamine-mediated potentiation of transient receptor potential (TRP) ankyrin 1 and TRP vanilloid 4 signaling in submucosal neurons in patients with irritable bowel syndrome.
    Balemans D, Aguilera-Lizarraga J, Florens MV, Jain P, Denadai-Souza A, Viola MF, Alpizar YA, Van Der Merwe S, Vanden Berghe P, Talavera K, Vanner S, Wouters MM, Boeckxstaens GE.
    Am J Physiol Gastrointest Liver Physiol; 2019 Mar 01; 316(3):G338-G349. PubMed ID: 30629470
    [Abstract] [Full Text] [Related]

  • 4. Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.
    Wouters MM, Balemans D, Van Wanrooy S, Dooley J, Cibert-Goton V, Alpizar YA, Valdez-Morales EE, Nasser Y, Van Veldhoven PP, Vanbrabant W, Van der Merwe S, Mols R, Ghesquière B, Cirillo C, Kortekaas I, Carmeliet P, Peetermans WE, Vermeire S, Rutgeerts P, Augustijns P, Hellings PW, Belmans A, Vanner S, Bulmer DC, Talavera K, Vanden Berghe P, Liston A, Boeckxstaens GE.
    Gastroenterology; 2016 Apr 01; 150(4):875-87.e9. PubMed ID: 26752109
    [Abstract] [Full Text] [Related]

  • 5. Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2.
    Valdez-Morales EE, Overington J, Guerrero-Alba R, Ochoa-Cortes F, Ibeakanma CO, Spreadbury I, Bunnett NW, Beyak M, Vanner SJ.
    Am J Gastroenterol; 2013 Oct 01; 108(10):1634-43. PubMed ID: 23958521
    [Abstract] [Full Text] [Related]

  • 6. Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms.
    Cenac N, Altier C, Chapman K, Liedtke W, Zamponi G, Vergnolle N.
    Gastroenterology; 2008 Sep 01; 135(3):937-46, 946.e1-2. PubMed ID: 18565335
    [Abstract] [Full Text] [Related]

  • 7. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes.
    Hughes PA, Harrington AM, Castro J, Liebregts T, Adam B, Grasby DJ, Isaacs NJ, Maldeniya L, Martin CM, Persson J, Andrews JM, Holtmann G, Blackshaw LA, Brierley SM.
    Gut; 2013 Oct 01; 62(10):1456-65. PubMed ID: 22767422
    [Abstract] [Full Text] [Related]

  • 8. Potentiation of TRPV4 signalling by histamine and serotonin: an important mechanism for visceral hypersensitivity.
    Cenac N, Altier C, Motta JP, d'Aldebert E, Galeano S, Zamponi GW, Vergnolle N.
    Gut; 2010 Apr 01; 59(4):481-8. PubMed ID: 20332520
    [Abstract] [Full Text] [Related]

  • 9. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.
    Shi HL, Liu CH, Ding LL, Zheng Y, Fei XY, Lu L, Zhou XM, Yuan JY, Xie JQ.
    World J Gastroenterol; 2015 Apr 28; 21(16):4852-63. PubMed ID: 25944998
    [Abstract] [Full Text] [Related]

  • 10. Important Study Adds to Understanding of the Pathophysiology of Visceral Hypersensitivity but Raises More Questions Than it Answers.
    Grabauskas G.
    Gastroenterology; 2016 Mar 28; 150(3):777. PubMed ID: 26827799
    [No Abstract] [Full Text] [Related]

  • 11. Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS.
    Perna E, Aguilera-Lizarraga J, Florens MV, Jain P, Theofanous SA, Hanning N, De Man JG, Berg M, De Winter B, Alpizar YA, Talavera K, Vanden Berghe P, Wouters M, Boeckxstaens G.
    Gut; 2021 Jul 28; 70(7):1275-1286. PubMed ID: 33023902
    [Abstract] [Full Text] [Related]

  • 12. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats.
    Winston J, Shenoy M, Medley D, Naniwadekar A, Pasricha PJ.
    Gastroenterology; 2007 Feb 28; 132(2):615-27. PubMed ID: 17258716
    [Abstract] [Full Text] [Related]

  • 13. 5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein-coupled receptor D.
    Bautzova T, Hockley JRF, Perez-Berezo T, Pujo J, Tranter MM, Desormeaux C, Barbaro MR, Basso L, Le Faouder P, Rolland C, Malapert P, Moqrich A, Eutamene H, Denadai-Souza A, Vergnolle N, Smith ESJ, Hughes DI, Barbara G, Dietrich G, Bulmer DC, Cenac N.
    Sci Signal; 2018 Dec 18; 11(561):. PubMed ID: 30563864
    [Abstract] [Full Text] [Related]

  • 14. Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons.
    Desormeaux C, Bautzova T, Garcia-Caraballo S, Rolland C, Barbaro MR, Brierley SM, Barbara G, Vergnolle N, Cenac N.
    Pain; 2018 Jul 18; 159(7):1257-1267. PubMed ID: 29554016
    [Abstract] [Full Text] [Related]

  • 15. Protease-activated receptor-4 (PAR 4): a role as inhibitor of visceral pain and hypersensitivity.
    Augé C, Balz-Hara D, Steinhoff M, Vergnolle N, Cenac N.
    Neurogastroenterol Motil; 2009 Nov 18; 21(11):1189-e107. PubMed ID: 19413681
    [Abstract] [Full Text] [Related]

  • 16. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H, Michel K, Schemann M.
    Gastroenterology; 2009 Oct 18; 137(4):1425-34. PubMed ID: 19596012
    [Abstract] [Full Text] [Related]

  • 17. Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patients.
    Hughes PA, Moretta M, Lim A, Grasby DJ, Bird D, Brierley SM, Liebregts T, Adam B, Blackshaw LA, Holtmann G, Bampton P, Hoffmann P, Andrews JM, Zola H, Krumbiegel D.
    Brain Behav Immun; 2014 Nov 18; 42():191-203. PubMed ID: 25063707
    [Abstract] [Full Text] [Related]

  • 18. NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons.
    King AJ, Chang L, Li Q, Liu L, Zhu Y, Pasricha PJ, Wang J, Siegel M, Caldwell JS, Edelstein S, Rosenbaum DP, Kozuka K.
    Am J Physiol Gastrointest Liver Physiol; 2024 May 01; 326(5):G543-G554. PubMed ID: 38252683
    [Abstract] [Full Text] [Related]

  • 19. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis.
    Li WT, Luo QQ, Wang B, Chen X, Yan XJ, Qiu HY, Chen SL.
    FASEB J; 2019 Feb 01; 33(2):2435-2450. PubMed ID: 30260705
    [Abstract] [Full Text] [Related]

  • 20. Symptom Generation by Mucosal Inflammation in Irritable Bowel Syndrome.
    Sarna SK, Winston JH.
    Gastroenterology; 2015 Aug 01; 149(2):287-9. PubMed ID: 26116796
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.